Rong H, Deftos L J, Ji H, Bucht E
Department of Molecular Medicine, Endocrine and Diabetes Unit, Karolinska Hospital and Institute, Stockholm, Sweden.
Clin Chem. 1997 Jan;43(1):71-5.
We recently developed a two-site immunofluorometric assay (IFMA) of salmon calcitonin (SCT) by DELFIA (dissociation enhancement lanthanide fluoroimmunoassay) technique using the same polyclonal antibodies both for "catching" the antigen and for signaling. In the present study we used a monoclonal antibody to SCT 1-11 as the capture antibody. This antibody was biotinylated before use in streptavidin-coated microtitration plates. The polyclonal antibody labeled with Eu chelate was used as a signaling marker. This combination of antibodies resulted in an assay that was three to four times more sensitive than the previous IFMA, with a detection limit of 0.3 pmol/L serum. Intact SCT 1-32 was detected by the assay (recoveries 94-96%), but not the fragments SCT 1-11 and SCT 10-32 or human calcitonin. Dilutions of plasma samples containing SCT were parallel to the calibration curve of SCT 1-32. Pharmacokinetic studies of SCT, 100 IU administered intramuscularly to 10 men, indicated peak serum concentrations of 32-128 pmol/L within 10-20 min with apparent half-life of 56+/-18 min (mean+/-SD). This new assay will allow study of the pharmacokinetics of new calcitonin preparations that do not require injection.
我们最近利用解离增强镧系元素荧光免疫分析(DELFIA)技术开发了一种鲑鱼降钙素(SCT)的双位点免疫荧光分析方法(IFMA),该方法使用相同的多克隆抗体进行“捕获”抗原和信号传导。在本研究中,我们使用抗SCT 1-11单克隆抗体作为捕获抗体。该抗体在用于包被链霉亲和素的微量滴定板之前进行了生物素化。用铕螯合物标记的多克隆抗体用作信号标记物。这种抗体组合产生的分析方法比之前的IFMA灵敏三到四倍,血清检测限为0.3 pmol/L。该分析方法可检测完整的SCT 1-32(回收率94-96%),但不能检测SCT 1-11和SCT 10-32片段或人降钙素。含有SCT的血浆样本稀释液与SCT 1-32的校准曲线平行。对10名男性肌肉注射100 IU SCT的药代动力学研究表明,10-20分钟内血清峰值浓度为32-128 pmol/L,表观半衰期为56±18分钟(平均值±标准差)。这种新的分析方法将有助于研究无需注射的新型降钙素制剂的药代动力学。